Top Markets
#1 Palladium Network Palladium Network +6.67%
#2 Victoria VR Victoria VR +4.08%
#3 Bridged NXPC Bridged NXPC +2.08%
#4 Tornado Cash Tornado Cash +2.06%
#5 龙虾 (Lobster) 龙虾 (Lobster) +1.72%
#6 aixbt by Virtuals aixbt by Virtuals +1.55%
#7 Prom Prom +1.52%
#8 SkyAI SkyAI +1.49%
#9 Wiki Cat Wiki Cat +1.14%
#10 Geodnet Geodnet +0.92%
Coin of the day
Palladium Network Palladium Network
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Classificação em ações #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Preço da ação
$0.0009
Última sincronização: 2025-05-27
Valor de mercado
$1.15K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Arch Therapeutics, Inc. (ARTH)

Categoria

Healthcare
Lucros da Arch Therapeutics, Inc. (ARTH)
Lucros em Jun 2024 TTM: $-12.26M
De acordo com os últimos relatórios financeiros da Arch Therapeutics, Inc., os ganhos atuais da empresa são de $-12.26M. Em 2022, a empresa teve ganhos de $-5.28M, um aumento em relação a aos ganhos de 2021, que foram de $-6.24M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Arch Therapeutics, Inc. de 2011 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $-12.26M 75.61%
2023 $-6.98M 32.35%
2022 $-5.28M -15.46%
2021 $-6.24M 33.02%
2020 $-4.69M 3.16%
2019 $-4.55M -5.53%
2018 $-4.81M -38.19%
2017 $-7.79M 29.98%
2016 $-5.99M 103.30%
2015 $-2.95M -63.80%
2014 $-8.14M 339.25%
2013 $-1.85M 4,963.48%
2012 $-36.61K 626.84%
2011 $-5.04K 0.00%
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -43,115.92%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -16,007.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -24,611.12%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR